These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 9260732

  • 41. Therapeutic Drug Monitoring of Phenytoin by Simple, Rapid, Accurate, Highly Sensitive and Novel Method and Its Clinical Applications.
    Shaikh AS, Guo R.
    Curr Pharm Biotechnol; 2017; 18(13):1098-1105. PubMed ID: 29437004
    [Abstract] [Full Text] [Related]

  • 42. Coadministration of phenytoin and felbamate: evidence of additional phenytoin dose-reduction requirements based on pharmacokinetics and tolerability with increasing doses of felbamate.
    Sachdeo R, Wagner ML, Sachdeo S, Shumaker RC, Lyness WH, Rosenberg A, Ward D, Perhach JL.
    Epilepsia; 1999 Aug; 40(8):1122-8. PubMed ID: 10448826
    [Abstract] [Full Text] [Related]

  • 43. Phenytoin pharmacokinetics in critically ill trauma patients.
    Boucher BA, Rodman JH, Jaresko GS, Rasmussen SN, Watridge CB, Fabian TC.
    Clin Pharmacol Ther; 1988 Dec; 44(6):675-83. PubMed ID: 3197366
    [Abstract] [Full Text] [Related]

  • 44. Phenytoin Michaelis-Menten pharmacokinetics in Caucasian paediatric patients.
    Bauer LA, Blouin RA.
    Clin Pharmacokinet; 1983 Dec; 8(6):545-9. PubMed ID: 6653035
    [Abstract] [Full Text] [Related]

  • 45. Integrated equation to evaluate accumulation profiles of drugs eliminated by Michaelis-Menten kinetics.
    Lam G, Chiou WL.
    J Pharmacokinet Biopharm; 1979 Apr; 7(2):227-32. PubMed ID: 20218016
    [Abstract] [Full Text] [Related]

  • 46. Effects of CYP2C19 and P450 oxidoreductase polymorphisms on the population pharmacokinetics of clobazam and N-desmethylclobazam in japanese patients with epilepsy.
    Saruwatari J, Ogusu N, Shimomasuda M, Nakashima H, Seo T, Tanikawa K, Tsuda Y, Nishimura M, Nagata R, Yasui-Furukori N, Kaneko S, Ishitsu T, Nakagawa K.
    Ther Drug Monit; 2014 Jun; 36(3):302-9. PubMed ID: 24345815
    [Abstract] [Full Text] [Related]

  • 47. Classical Michaelis-Menten and system theory approach to modeling metabolite formation kinetics.
    Popović J.
    Eur J Drug Metab Pharmacokinet; 2004 Jun; 29(3):205-14. PubMed ID: 15537173
    [Abstract] [Full Text] [Related]

  • 48. The effect of multiple anticonvulsant therapy on the expression of phenytoin-induced gingival overgrowth.
    Kamali F, McLaughlin WS, Ball DE, Seymour RA.
    J Clin Periodontol; 1999 Dec; 26(12):802-5. PubMed ID: 10599907
    [Abstract] [Full Text] [Related]

  • 49. Disposition of phenytoin in critically ill trauma patients.
    Boucher BA, Rodman JH, Fabian TC, Cupit GC, Ludden TM, West ME, Ray MW.
    Clin Pharm; 1987 Nov; 6(11):881-7. PubMed ID: 3677565
    [Abstract] [Full Text] [Related]

  • 50. Genetic polymorphisms and functional characterization of the 5'-flanking region of the human CYP2C9 gene: in vitro and in vivo studies.
    Shintani M, Ieiri I, Inoue K, Mamiya K, Ninomiya H, Tashiro N, Higuchi S, Otsubo K.
    Clin Pharmacol Ther; 2001 Aug; 70(2):175-82. PubMed ID: 11503012
    [Abstract] [Full Text] [Related]

  • 51. Altered phenytoin pharmacokinetics in children with severe, acute traumatic brain injury.
    Stowe CD, Lee KR, Storgion SA, Phelps SJ.
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1452-61. PubMed ID: 11185666
    [Abstract] [Full Text] [Related]

  • 52. Phenytoin age-dose-concentration relationship in children.
    Suzuki Y, Mimaki T, Cox S, Koepke J, Hayes J, Walson PD.
    Ther Drug Monit; 1994 Apr; 16(2):145-50. PubMed ID: 8009561
    [Abstract] [Full Text] [Related]

  • 53. Pharmacokinetics of phenytoin in children with acute neurotrauma.
    O'Mara NB, Jones PR, Anglin DL, Cox S, Nahata MC.
    Crit Care Med; 1995 Aug; 23(8):1418-24. PubMed ID: 7634814
    [Abstract] [Full Text] [Related]

  • 54. Effect of over-the-counter cimetidine on phenytoin concentrations in patients with seizures.
    Rafi JA, Frazier LM, Driscoll-Bannister SM, O'Hara KA, Garnett WR, Pugh CB.
    Ann Pharmacother; 1999 Aug; 33(7-8):769-74. PubMed ID: 10466901
    [Abstract] [Full Text] [Related]

  • 55. Effect of 'Mentat' on the pharmacokinetics of single and multiple doses o phenytoin in rabbits.
    Garg SK, Islam AS, Kumar N, Sehgal M, Bhargava VK.
    Neurol India; 1999 Jun; 47(2):104-7. PubMed ID: 10402333
    [Abstract] [Full Text] [Related]

  • 56. Effect of mild therapeutic hypothermia on phenytoin pharmacokinetics.
    Iida Y, Nishi S, Asada A.
    Ther Drug Monit; 2001 Jun; 23(3):192-7. PubMed ID: 11360024
    [Abstract] [Full Text] [Related]

  • 57. Lack of pharmacokinetic interaction between grapefruit juice and phenytoin in healthy male volunteers and epileptic patients.
    Kumar N, Garg SK, Prabhakar S.
    Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):629-32. PubMed ID: 10669910
    [Abstract] [Full Text] [Related]

  • 58. CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects.
    Franco V, Perucca E.
    Expert Opin Drug Metab Toxicol; 2015 Nov; 11(8):1269-79. PubMed ID: 26037375
    [Abstract] [Full Text] [Related]

  • 59. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E, Cloyd J, Critchley D, Fuseau E.
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [Abstract] [Full Text] [Related]

  • 60. The effect of orlistat on the pharmacokinetics of phenytoin in healthy volunteers.
    Melia AT, Mulligan TE, Zhi J.
    J Clin Pharmacol; 1996 Jul; 36(7):654-8. PubMed ID: 8844449
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.